Abstract
Background In dermatology, corticosteroids are the most frequently prescribed medication group. The goal of this study was to examine the prescription pattern of glucocorticoids in patients with skin diseases in outpatient dermatology departments (OPD) in tertiary care hospitals.
Methods A prospective, multi-centered, cross-sectional study was undertaken in the dermatology department of government affiliated private medical College hospitals in Chittagong, Bangladesh, from March 2021 to April 2022. A total of 450 prescriptions from dermatology out-patient department patients with skin diseases were obtained and evaluated for demographics, skin diseases, and corticosteroid use patterns.
Result Out of 450 patients, majority belonged to the age group 21-40 years (44%) and were female (56%). The most frequent indication for prescribing corticosteroids were eczema (20%) urticaria (17%) and allergic Contact dermatitis (7%) and psoriasis (7%). The commonest corticosteroids used were betamethasone (19%) and Clobetasol proprionate (17%), Deflazacort (15%). Use of topical steroid combinations with Fusidic acid and Miconazole nitrate were prevalent, (4%) and (5%), respectively. Highly potent steroids were used in 51% cases whereas only 21% were given low potency steroids.
Conclusion Physicians prefer highly potent corticosteroids, according to this study. To improve prescribing, physicians should receive ongoing medical education and be made aware of the irrational use of steroids. Researchers and policymakers can use the baseline data acquired in these studies to enhance judicial prescribing practices. Keywords: Corticosteroids, dermatology, prescribing pattern.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No fund received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol has been approved by the BGC trust medical college's institutional review board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
yes
